Séverine Vermeire is Professor of Medicine and Head of the Department of Chronic Diseases, Metabolism & Ageing (CHROMETA) at the University of Leuven (KU Leuven), Belgium. She graduated with an MD from the University of Leuven and completed training in gastroenterology at the Universidad Nacional de Asunción, San Lorenzo, Paraguay, and at the Montreal General Hospital (McGill University), Montreal, Quebec, Canada. In 2001, she obtained her PhD on “Genetic polymorphisms and serologic markers in inflammatory bowel disease” as a Fellow of the Fund for Scientific Research (FWO) Belgium. Professor Vermeire carried out some of the research for her PhD at the Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK, with Professor Derek Jewell. Professor Vermeire has held a staff position at the Division of Gastroenterology and Hepatology of the University Hospitals Leuven since 2003.
Professor Vermeire’s scientific work focuses on the genetics and pharmacogenetics of inflammatory bowel disease (IBD), the role of the microbiome in IBD, prediction of outcomes and therapeutic response in IBD and aspects related to immunogenicity of biological therapies. These research lines have resulted in more than 500 peer-reviewed full papers and an h-index of 96. In 2016, she was awarded a European Research Council (ERC) Advanced Research Grant for her scientific work.
Professor Vermeire served as Associate Editor for Gut from 2004 to 2010 and the Journal of Crohn’s and Colitis from 2009 to 2017. She is a past president of the Belgian Inflammatory Bowel Disease Research and Development Group (BIRD) and a past president of the European Crohn’s and Colitis Organisation (ECCO).